Target Name: NIF3L1
NCBI ID: G60491
Review Report on NIF3L1 Target / Biomarker Content of Review Report on NIF3L1 Target / Biomarker
NIF3L1
Other Name(s): CALS-7 | amyotrophic lateral sclerosis 2 chromosomal region candidate gene 1 protein | NGG1 interacting factor 3 like 1 | NIF3-like protein 1 (isoform 1) | Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 1 | MDS015 | NIF3L_HUMAN | NIF3 (Ngg1 interacting factor 3, S.pombe homolog)-like 1 | GTP cyclohydrolase I | ALS2CR1 | NIF3 NGG1 interacting factor 3-like 1 | NIF3-like protein 1 | NIF3L1 variant 1 | NGG1 interacting factor 3 like 1, transcript variant 1 | putative GTP cyclohydrolase 1 type 2 NIF3L1 | amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 1 | Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 1 protein

Understanding NIF3L1: A Protein Involved in Cell Division and Growth

NIF3L1 (CALS-7) is a protein that is expressed in various tissues throughout the body, including the brain, heart, lungs, and kidneys. It is a key regulator of the cytoskeleton, which is the structure that gives cells their shape and supports their movement.

NIF3L1 is also a potent modifier of the cytoskeleton, allowing it to alter the size and shape of cells. This property makes NIF3L1 an attractive drug target, as researchers are interested in finding ways to target the NIF3L1 protein and regulate its activity.

One way that researchers are investigating NIF3L1 is to use small molecules, such as drugs, to alter its activity. This approach is based on the idea that drugs can interact with specific proteins and cause them to behave differently. Researchers are using a variety of techniques to identify potential small molecules that can interact with NIF3L1 and modify its activity.

Another approach that researchers are using to investigate NIF3L1 is to study its structure and function. This is done through a variety of techniques, including X-ray crystallography, which allows researchers to study the three-dimensional structure of NIF3L1 in great detail.

By studying the structure and function of NIF3L1, researchers have gained new insights into its role in the cytoskeleton and how it functions as a drug target. One of the key findings of these studies is that NIF3L1 is involved in the regulation of cell division and growth.

NIF3L1 is a protein that is expressed in various tissues throughout the body and is involved in the regulation of cell division and growth. As a result, it is an attractive drug target for researchers who are interested in finding ways to target the NIF3L1 protein and regulate its activity. By using a variety of techniques, including small molecules and X-ray crystallography, researchers are working to understand the role of NIF3L1 in the cytoskeleton and how it functions as a drug target.

Protein Name: NGG1 Interacting Factor 3 Like 1

Functions: May function as a transcriptional corepressor through its interaction with COPS2, negatively regulating the expression of genes involved in neuronal differentiation

The "NIF3L1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NIF3L1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NIFK | NIFK-AS1 | NIHCOLE | NIM1K | NIN | NINJ1 | NINJ2 | NINJ2-AS1 | NINL | NIP7 | NIPA1 | NIPA2 | NIPAL1 | NIPAL2 | NIPAL3 | NIPAL4 | NIPBL | NIPBL-DT | NIPSNAP1 | NIPSNAP2 | NIPSNAP3A | NIPSNAP3B | NISCH | NIT1 | NIT2 | Nitric oxide synthase (NOS) | NKAIN1 | NKAIN1P1 | NKAIN2 | NKAIN3 | NKAIN4 | NKAP | NKAPD1 | NKAPL | NKAPP1 | NKD1 | NKD2 | NKG7 | NKILA | NKIRAS1 | NKIRAS2 | NKPD1 | NKRF | NKTR | NKX1-1 | NKX1-2 | NKX2-1 | NKX2-1-AS1 | NKX2-2 | NKX2-3 | NKX2-4 | NKX2-5 | NKX2-6 | NKX2-8 | NKX3-1 | NKX3-2 | NKX6-1 | NKX6-2 | NKX6-3 | NLE1 | NLGN1 | NLGN1-AS1 | NLGN2 | NLGN3 | NLGN4X | NLGN4Y | NLK | NLN | NLRC3 | NLRC4 | NLRC4 Inflammasome | NLRC5 | NLRP1 | NLRP1 Inflammasome | NLRP10 | NLRP11 | NLRP12 | NLRP13 | NLRP14 | NLRP2 | NLRP2B | NLRP3 | NLRP3 Inflammasome | NLRP3P1 | NLRP4 | NLRP5 | NLRP6 | NLRP7 | NLRP8 | NLRP9 | NLRP9P1 | NLRX1 | NMB | NMBR | NMD3 | NMDA receptor | NME1 | NME1-NME2 | NME2 | NME2P1